1. Home
  2. EWTX vs IPAR Comparison

EWTX vs IPAR Comparison

Compare EWTX & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$27.96

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Logo Inter Parfums Inc.

IPAR

Inter Parfums Inc.

HOLD

Current Price

$95.08

Market Cap

3.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EWTX
IPAR
Founded
2017
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.1B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
EWTX
IPAR
Price
$27.96
$95.08
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$36.00
$125.50
AVG Volume (30 Days)
703.0K
240.9K
Earning Date
05-27-2026
05-11-2026
Dividend Yield
N/A
3.34%
EPS Growth
N/A
7.79
EPS
N/A
4.36
Revenue
N/A
$1,317,700,000.00
Revenue This Year
N/A
$4.47
Revenue Next Year
N/A
$8.23
P/E Ratio
N/A
$21.93
Revenue Growth
N/A
21.26
52 Week Low
$10.60
$77.21
52 Week High
$31.82
$142.50

Technical Indicators

Market Signals
Indicator
EWTX
IPAR
Relative Strength Index (RSI) 43.04 41.32
Support Level $27.00 $92.30
Resistance Level $31.12 $102.38
Average True Range (ATR) 1.36 3.49
MACD -0.40 -1.32
Stochastic Oscillator 18.74 26.22

Price Performance

Historical Comparison
EWTX
IPAR

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

Share on Social Networks: